Haematopoetic Stem Cells

Researchers boost platelet production from cord blood hematopoietic stem/progenitor cells using a defined 3D culture system

A new study shakes the hematopoietic foundations and reveals a new view of how blood is formed in mice.

A new study demonstrates that normal and leukemic blood stem cells fight for the same niche with consequences for cancer treatment and transplantation.

The results of a new trial demonstrate an improved method to deliver stem cells to the failing heart.

In a boost to transplantation based therapies, a new study finds that the application of a widely used immunosuppressant drug can inhibit the loss of stem cell functionality caused by the ambient oxygen concentrations encountered during bone marrow harvesting.

Researchers link physiological stress to HSC activation, increased DNA damage, and cell and tissue dysfunction.

Hematopoietic stem cell transplantation improves clinical outcomes in multiple sclerosis; the first evidence of a successful treatment for this disease.

Researchers experimentally mimic the “Berlin patient” by creating an HIV-resistant selectable stem cell population which can reconstitute the mouse hematopoietic system and resist HIV infection

Hematopoietic stem cells differentiate into macrophages and correct a lysosomal storage disorder through nanotube-mediated lysosomal exchange

Early intervention with autologous blood stem/progenitor cells shows promise in promoting functional recovery and reduces lesion volume after ischemic stroke